|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00187993 |
|
Date of registration:
|
12/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
|
|
Scientific title:
|
Growth Hormone Treatment of Young Adults Deficient in Growth Hormone Since Childhood : Study of Body Composition Modifications. |
|
Date of first enrolment:
|
May 2005 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00187993 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Defined Population, Time Perspective: Longitudinal
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Rohmer Vincent, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
CHU of Angers |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adults (age > 18-35 years)
- Stable body mass +/- 5 kg in 3 months
- GH deficiency since childhood, treated by GH during childhood, having stopped GH
treatment at the end of adolescence
- Want to receive again GH treatment or refusing new GH treatment
- GH deficiency confirmed at adulthood by GHRH-Arginine test
- Women receiving GH treatment must have a efficient contraceptive method
- Have given a writing informed consent
Exclusion Criteria:
- Somatotropic insufficiency
- All pathologies or treatment modifing energetic metabolism, excepted diabet mellitus
and obesity
- Participating to another clinical trial during the three months befor inclusion
- Pathologies modifing bone metabolism
- Pregnancy/Feeding
- Refusal to consent
Age minimum:
18 Years
Age maximum:
35 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Growth Hormone Deficiency
|
|
Intervention(s)
|
|
Drug: Growth hormone
|
|
Secondary ID(s)
|
|
0673 (AFSSAPS)
|
|
2004/10 (CCPPRB)
|
|
CP-04-03
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|